BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 21, 2004
View Archived Issues
License termination agreement returns LEP and LED rights to NeoPharm
Read More
BioMimic formed to develop human applications of Receptor Mimic Technology
Read More
Novel DNA cancer vaccine enters phase I trial
Read More
Enrollment completed in phase I dose escalation study of DB-289 for malaria
Read More
EMZ-702 enters clinical development for hepatitis C
Read More
Final results of Sanofi-Aventis' offer for Aventis
Read More
IDEA-033 enters phase III study for peripheral pain
Read More
Novel L-DOPA prodrugs designed by Yissum researchers
Read More
New antitumor agents prepared and tested at Dr. Reddy's
Read More
New p38 MAP kinase inhibitors emerge from Pfizer R&D
Read More
CV Therapeutics presents new adenosine A1 agonists and their use as antiarrhythmic agents
Read More
New fatty acid oxidation inhibitors in early development at CV Therapeutics
Read More
Pfizer presents new TGF-beta type II receptor kinase inhibitors
Read More
BMS scientists identify new calcium-sensing receptor antagonists
Read More
New antitumor pregnene derivative isolated from gorgonian species
Read More
Complete response for Symlin submitted to FDA
Read More
Proquin XR NDA accepted by FDA
Read More
Isis licenses second antisense anticancer drug candidate to Lilly
Read More
FDA accepts sBLA for expanded use of Bexxar
Read More
Positive preliminary phase III results with M6G in postoperative pain
Read More
New diagnostic test for early detection of invasive fungal infections
Read More
New phase I data on the safety profile of cantuzumab mertansine in advanced cancer
Read More
Clinical evidence confirms the positive effects of etanercept in psoriasis and rheumatoid arthritis
Read More
Rasagiline improves motor symptoms and tremor in PD
Read More
Tacrolimus and ciclosporin equally affect glucose metabolism after pancreas transplantation
Read More
Statins reported to improve survival of patients with advanced heart failure
Read More
Theophylline improves the efficacy of standard therapy for asthma attacks
Read More
Marketing approval for Hexvix
Read More
European marketing authorization submitted for once-monthly oral formulation of Bonviva
Read More
Approvable letter for Extravan for glaucoma
Read More
Expanded indication for Eloxatin for early stage colon cancer treatment
Read More
